Search
Search Results
##search.searchResults.foundPlural##
-
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
966PDF: 531HTML: 720 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4071PDF: 1234HTML: 1952Table 1: 191 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2232PDF: 865HTML: 2092 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2067PDF: 604Suppl. Files: 283HTML: 164 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2021PDF: 818HTML: 209 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2301PDF: 925HTML: 300 -
EPIDEMIOLOGY OF MALARIA IN ENDEMIC AREAS
5279PDF: 2630HTML: 49564 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3176PDF: 773HTML: 2945Figure 1a and 1b: 145Figure 2: 156Figure 3: 174Figure 4: 157Figure 5: 160Tables 1-5: 151 -
PROPHYLAXIS OF MALARIA
2995PDF: 1016HTML: 17791Figures SChwartz: 160 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
815PDF: 536HTML: 4015 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1959PDF: 742HTML: 694 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3987PDF: 1048HTML: 3586Untitled: 174Cneo. Fig.1: 111Untitled: 102Untitled: 125Untitled: 129 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2464PDF: 919HTML: 519 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2779PDF: 1112HTML: 11215 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
636PDF: 491HTML: 84 -
-
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4045PDF: 1920HTML: 5222Table 1: 189 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1180PDF: 1059HTML: 197 -
-
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7413PDF: 2414HTML: 1724Table 1.: 205Table 2.: 215Table 3.: 197Table 4.: 198 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1287PDF: 1008HTML: 120 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2228PDF: 875HTML: 1999Fig 1 Rossi: 173 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4283PDF: 1368HTML: 2035 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2165PDF: 1473HTML: 262 -
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
166PDF: 176HTML: 12 -
POST-LOAD PLASMA GLUCOSE INCREASE (PG-GAP) AS A RISK FACTOR FOR DEVELOPING DYSGLYCEMIA IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (Β-TDT): RETROSPECTIVE ANALYSIS OVER 8 YEARS Post load plasma glucose increase and the risk of glucose dysregulation in thalassemia
485PDF: 238HTML: 37 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
622PDF: 219Html: 31 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
686PDF: 370Suppl. Files: 117HTML: 110







